NAD treatment refers to any therapy designed to raise levels of nicotinamide adenine dinucleotide (NAD+), a molecule every cell in your body uses to produce energy, repair DNA, and regulate aging-related processes. The treatments range from multi-hour intravenous infusions at specialized clinics to daily oral supplements you can buy online. Interest has surged because NAD+ levels drop as you age, and animal research links that decline to metabolic disease, neurodegeneration, and cardiovascular problems. But the human evidence is thinner than the marketing suggests, the delivery methods work differently than most people assume, and the costs vary enormously depending on which route you choose.
What NAD+ Does in Your Body
NAD+ is not a vitamin or a hormone. It is a coenzyme, a helper molecule that participates in hundreds of chemical reactions inside your cells. Its two biggest jobs are shuttling electrons during energy production and serving as fuel for enzymes involved in DNA repair and gene regulation. Without adequate NAD+, your mitochondria struggle to convert food into usable energy, and your cells lose some of their ability to fix damaged DNA and manage inflammation.1Circulation. NAD(+) Metabolism in Cardiac Health, Aging, and Disease
Two families of enzymes that depend on NAD+ get particular attention in aging research. Sirtuins are a group of enzymes that influence inflammation, stress resistance, and metabolism. PARPs are enzymes that detect and help repair DNA damage. Both consume NAD+ as they work, so when NAD+ is scarce, these repair and maintenance systems slow down.2PubMed Central. NAD+ and sirtuins in aging and disease That competition for a shrinking pool of NAD+ is one reason researchers think age-related decline in the molecule has such wide-reaching effects.
Why NAD+ Drops With Age
Multiple lines of evidence confirm that NAD+ levels fall over time in human tissues, though the exact pace and magnitude vary by organ.3PubMed Central. Age-related NAD+ decline The decline is not simply a matter of your body making less NAD+. One major driver is an enzyme called CD38, whose activity rises with age. CD38 chews through NAD+ at an increasing rate as you get older, and in mouse studies, it has been shown to be required for the age-related drop in NAD+ levels and the mitochondrial dysfunction that follows.4PubMed Central. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism
Obesity and high blood pressure also accelerate NAD+ loss. In preclinical models, replenishing NAD+ has been shown to extend healthspan, prevent metabolic syndrome, and reduce blood pressure.1Circulation. NAD(+) Metabolism in Cardiac Health, Aging, and Disease Those animal results are what fueled the explosion of consumer NAD+ products, but translating them to humans has proven complicated.
How NAD+ Treatments Are Delivered
There are two broad approaches: intravenous infusions and oral supplements. They work quite differently and are not interchangeable in how they affect your body.
IV NAD+ Infusions
Clinics offering NAD+ drips typically administer the molecule directly into a vein over several hours. The idea is straightforward: bypass the gut and flood the bloodstream with NAD+. In practice, the pharmacology is more surprising. A pilot study tracking what happens during a six-hour IV infusion found that plasma NAD+ levels did not rise at all for the first two hours. The molecule was being removed from the blood almost as fast as it was delivered. By the end of the infusion, metabolic byproducts showed up in urine, suggesting the body was rapidly breaking down the incoming NAD+ rather than storing it intact.5PubMed Central. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD
A small randomized pilot trial comparing IV NAD+ to IV nicotinamide riboside (NR, a precursor molecule) found that NAD+ given intravenously produced only modest increases in whole blood NAD+ levels, about 2% at 24 hours and 15% by two weeks. IV NR, by contrast, caused a quicker spike of roughly 21% at three hours, which tapered off over the following days. Neither approach produced a dramatic, sustained jump.6medRxiv. Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults This matters because the premise of a $750-to-$1,500 infusion is that you are getting a large, immediate boost. The data so far suggest the body handles IV NAD+ more like a slow trickle than a flood.
Oral Supplements
The two most popular oral precursors are nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). These are not NAD+ itself but molecules your body can convert into NAD+. A third option, plain nicotinamide (a form of vitamin B3), also feeds into NAD+ production through a different route.
For years, researchers assumed NMN and NR were absorbed intact from the gut and converted to NAD+ inside cells through a fairly direct pathway. More recent work has upended that picture. Studies using isotope-labeled compounds show that most orally taken NMN and NR gets broken down by gut bacteria into nicotinic acid, a different form of B3, before it eventually becomes NAD+ through a roundabout metabolic pathway centered on the liver.7PubMed Central. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD(+) synthesis via enterohepatic circulation Separately, cell-level studies have shown that NMN is converted to NR outside the cell before it can even be taken up.8PubMed Central. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Research using human gut microbiota confirmed this gut-dependent model: NR and NMN give rise to nicotinic acid through microbial metabolism, and that nicotinic acid turned out to be a potent NAD+ booster in whole blood, while NMN, NR, and plain nicotinamide were not.9PubMed Central. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans The practical takeaway is that your gut bacteria play a larger role in NAD+ supplementation than anyone expected, and the premium-priced precursors may be working through the same cheap metabolic intermediary. This does not mean they are useless, but it does mean the mechanism is less exclusive than the supplement branding implies.
What the Evidence Shows for Benefits
The gap between animal data and human data in NAD+ research is wide. In mice and other model organisms, boosting NAD+ improves almost everything researchers have looked at. In humans, the picture is more modest and more specific.
Metabolic Health
The strongest human clinical result so far comes from a trial of NMN supplementation in overweight or obese women with prediabetes. After supplementation, muscle insulin sensitivity improved, along with insulin signaling pathways in skeletal muscle. The placebo group showed no such change.10PubMed Central. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women This is encouraging, but it is a single trial in a specific population. Whether NAD+ precursors benefit metabolic health in people who are already healthy, or in men, or in people with established diabetes rather than prediabetes, remains unclear.
Heart Failure
A randomized, placebo-controlled trial in patients with heart failure caused by ischemic cardiomyopathy found that those receiving NAD+ had a greater improvement in heart pumping ability at one month compared to placebo. The NAD+ group’s ejection fraction improved to about 45% versus roughly 42% in the placebo group.11PubMed Central. Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial That is a meaningful difference for someone with heart failure, but the study was small, and NAD+ did not significantly change the heart’s structural dimensions. Preclinical research suggests depleted NAD+ in heart cells leads to inadequate energy production, making the heart more vulnerable to failure.12PubMed Central. NAD+-A Hub of Energy Metabolism in Heart Failure Larger trials are needed before NAD+ supplementation could be considered a treatment for cardiac disease.
Brain Health
NAD+ research in neurology is almost entirely preclinical. Review literature has identified roles for NAD+ in helping neurons adapt to stress and counteract processes involved in Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.13PubMed Central. NAD+ in Brain Aging and Neurodegenerative Disorders In a mouse model, NR supplementation reduced brain inflammation and improved markers of mitochondrial energy production.14PubMed. Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model No randomized human trial has demonstrated cognitive improvement from NAD+ therapy, though several are underway.
Exercise Performance
Despite the energy-production angle, NAD+ supplementation does not appear to help healthy people exercise better. A review of both animal and human NR supplementation studies concluded that NAD+ therapies do not alter skeletal muscle metabolism or improve athletic performance in healthy humans.15PubMed Central. NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans If you are already healthy and training regularly, NAD+ supplements are unlikely to give you an edge.
Addiction and Withdrawal
IV NAD+ has been marketed aggressively by some addiction clinics as a treatment for substance abuse withdrawal. The biological rationale is that raising intracellular NAD+ levels could help manage cravings and withdrawal symptoms.16PubMed Central. Sobriety and Satiety: Is NAD+ the Answer? However, the clinical evidence for this use case consists mainly of case reports and mechanistic speculation. No large randomized trial has validated NAD+ as an addiction treatment. Patients seeking help for substance use disorders should not rely on NAD+ infusions as a substitute for evidence-based treatments.
Side Effects and Safety
The side-effect profile depends heavily on how you take it. Oral NMN appears well tolerated in the short term. A safety study found that doses up to 1,250 mg per day for four weeks produced no severe adverse events and no clinically meaningful changes in blood work, urine, or body composition in healthy adults.17Scientific Reports. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women A systematic review and meta-analysis of NMN trials with doses ranging from 250 to 2,000 mg per day and durations up to 24 weeks found no increase in overall adverse events, serious adverse events, or liver enzyme elevations compared to placebo.18PubMed Central. Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis That said, these trials had limited sample sizes and short durations, and the authors stressed that rare, delayed, or long-term risks cannot be ruled out.
IV NAD+ infusions are a different story. A retrospective tolerability study found that all participants receiving direct NAD+ infusions reported moderate to severe symptoms during the drip, including abdominal cramping, diarrhea, nausea, vomiting, increased heart rate, throat pain, chest pressure, and congestion. These symptoms stopped immediately when the infusion ended.19PubMed Central. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting Clinics sometimes slow the drip rate to manage these reactions, which is part of why infusions can take four to six hours. The discomfort is not life-threatening based on published data, but it is substantial enough that anyone considering an IV session should know what to expect.
A more unsettling concern is theoretical but worth mentioning: cancer cells also rely on NAD+ for their rapid growth and energy demands. A scoping review concluded that further research is needed into whether raising NAD+ levels could inadvertently promote tumor growth, particularly given that some of the same protective enzymes (sirtuins) have been found to have both anti-cancer and pro-cancer functions depending on context.20PubMed Central. Nicotinamide adenine dinucleotide and the sirtuins caution: Pro-cancer functions No human study has shown that NAD+ supplementation causes cancer, but the lack of long-term data in large populations means this question is genuinely open.21PubMed Central. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update
What NAD+ Treatment Costs
IV NAD+ infusions at wellness clinics typically run between $500 and $1,500 per session, with some clinics charging more for longer infusion protocols or multi-session packages. A “loading phase” of several sessions in a week, commonly marketed for anti-aging or addiction, can easily exceed $5,000. Insurance almost never covers these infusions because they are not FDA-approved treatments for any specific condition.
Oral supplements are dramatically cheaper. A month’s supply of NMN or NR from a reputable brand generally costs between $30 and $100, depending on dose and manufacturer. Plain nicotinamide, the ordinary B3 form, costs only a few dollars per month. Given the recent findings that NMN and NR are largely broken down into simpler B3 metabolites in the gut before being converted to NAD+, the cost-per-unit-of-actual-NAD+-produced may be less different between premium precursors and basic niacin forms than the price tags suggest. This is an active area of investigation, and no study has done a head-to-head cost-effectiveness comparison, but the metabolic data are worth keeping in mind before committing to an expensive regimen.
NAD+ supplements are sold as dietary supplements in the United States, meaning they do not undergo FDA review for safety or efficacy before reaching the market. The FDA has at times questioned the regulatory status of NMN specifically, leading to marketplace uncertainty. Quality and purity vary between manufacturers, and third-party testing is voluntary. If you do opt for oral supplements, choosing a brand that provides certificates of analysis from independent labs is a basic safeguard.
The CD38 Problem and Emerging Alternatives
One reason some researchers are skeptical of the “just add more NAD+” approach is that it does not address why levels dropped in the first place. If the enzyme CD38 is degrading NAD+ at an accelerating rate as you age, simply flooding the system with more NAD+ or its precursors may be fighting a losing battle against an ever-hungrier drain.22PubMed Central. The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
This has led to interest in CD38 inhibitors as an alternative or complementary strategy. Apigenin, a flavonoid found in parsley, chamomile, and celery, has been shown to inhibit CD38 and raise intracellular NAD+ levels in cell culture.23PubMed Central. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome Quercetin, another plant flavonoid, has shown similar potential. In skin cell experiments, quercetin combined with exogenous NAD+ produced greater protective effects against aging markers than NAD+ alone, with the combination improving sirtuin activation, autophagy, and mitochondrial function.24PubMed Central. Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD+) by Synergistic Inhibition of CD38 Expression Pharmaceutical development of more potent CD38 inhibitors is underway, with researchers framing CD38 inhibition as a way to restore NAD+ balance rather than simply pushing more raw material into the system.25PubMed Central. Emerging chemical strategies for CD38 inhibition: restoring NAD(+) metabolism and disease control None of these approaches have reached the stage of clinical trials for aging in humans, but the concept addresses a genuine limitation of current NAD+ therapies.
NAD+ and Your Body Clock
One of the more interesting findings in NAD+ biology is that the molecule does not sit at a steady level throughout the day. NAD+ levels oscillate on a circadian rhythm. The enzyme responsible for the rate-limiting step in NAD+ production, NAMPT, is directly controlled by the core molecular clock, and the NAD+ it produces in turn feeds back to regulate that same clock through sirtuin activity.26PubMed Central. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis In other words, NAD+ is not just a passive fuel source but an active participant in keeping your daily biological rhythms synchronized.
This raises questions that have not been answered yet. Could declining NAD+ levels contribute to the sleep disruption and circadian drift that commonly accompany aging? Would timing NAD+ supplementation to align with the natural peak of NAMPT activity make it more effective? Would taking it at the wrong time blunt the circadian signal? These are not idle hypotheticals — they touch on a fundamental gap in the supplementation research, where nearly all trials have participants take a pill once a day without considering the body’s own rhythmic demand for NAD+.
NAD+ for Skin Aging
Beyond systemic supplements, NAD+ and its precursors are showing up in topical skincare formulations. Nicotinamide (niacinamide) has been a staple in dermatology for years, but newer research is looking at whether boosting NAD+ directly in skin cells can counteract both sun damage and intrinsic aging. In a mouse study, nicotinamide supplementation restored the expression of skin barrier proteins and collagen while reducing markers of cellular aging and the inflammatory signals that senescent cells pump out.27PubMed Central. Nicotinamide Improves Skin Photoaging in Mice by Delaying Cellular Senescence and Suppressing the Senescence-Associated Secretory Phenotype The dual mechanism — slowing down cellular aging and quieting the damage signals from already-aged cells — is what makes the approach interesting compared to simple moisturization or sunscreen.
Whether slathering NAD+ on your skin or swallowing a pill that eventually becomes NAD+ somewhere in your liver can meaningfully affect skin aging in living humans is another matter. The cell culture and mouse data are promising, but the gap between fibroblasts in a dish and a human face is enormous. For now, topical niacinamide at concentrations around 4-5% is the form with the most real-world dermatological support, while direct NAD+ topical products remain speculative.